Cherry Creek Investment Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Buy |
64,132
+535
| +0.8% | +$2.71K | 0.15% | 85 |
|
|
2025
Q1 | $336K | Buy |
63,597
+1,470
| +2% | +$7.78K | 0.18% | 82 |
|
|
2024
Q4 | $420K | Buy |
62,127
+4,787
| +8% | +$32.4K | 0.21% | 67 |
|
|
2024
Q3 | $378K | Sell |
57,340
-35,998
| -39% | -$237K | 0.2% | 70 |
|
|
2024
Q2 | $700K | Buy |
93,338
+35,782
| +62% | +$268K | 0.37% | 45 |
|
|
2024
Q1 | $574K | Buy |
57,556
+39,703
| +222% | +$396K | 0.31% | 52 |
|
|
2023
Q4 | $176K | Buy |
+17,853
| New | +$176K | 0.11% | 96 |
|